Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Dimpy P. Shah, M.D.; Ph.D.

Contact

210-562-6503

shahdp@uthscsa.edu

Departments & Divisions

Institutes & Centers

Research

Research profile

Dimpy P. Shah, M.D., Ph.D.

Assistant Professor

My research program focuses on multi-institutional collaborations for utilization of existing databases and biorepositories, development of outcome prediction algorithms, and examination of host-microbe-environment relationship to improve cancer prevention and survivorship. I have ongoing programs of research in various areas of cancer epidemiology and risk assessment, including descriptive studies, viral studies, occupational exposures, general environmental exposures, tobacco use and lifestyle factors, immunoepidemiology, genetic susceptibility, and microbiome-metabolome interactions. In addition to my research activity, I serve as Advisory Council Member for Texas Cancer Registry; Member of Shared Resources Oversight Committee; Founding Member of Respiratory Viral Infection Consortium; Member of Hepatocellular Carcinoma Epidemiology Consortium; and Steering Committee Member and Co-Lead of Epidemiology/Statistics committee for COVID19 and Cancer Consortium (CCC19).

  • Professional Background

    Education

    • 2014 - PhD - Epidemiology - The University of Texas at Houston School of Public Health
    • 2008 - MS - Epidemiology - Texas A&M Health Science Center School of Rural Public Health
    • 2005 - MD - Medicine (Ophthalmology; Biochemistry) - Seth G. S. Medical College K.E.M. Hospital

    Appointments

    • 6/2017 - Adjunct Assistant Professor - The University of Texas School of Public Health, Epidemiology, Human Genetics and Environmental Sciences, Houston
    • 6/2017 - Assistant Professor - UT Health San Antonio, Population Health Sciences, San Antonio

  • Instruction & Training

    • 1/2018 - Present, Patient Orient Clin Res Method-2, The University of Texas Health Science Center

  • Research & Grants

    Hematologic Malignancies, Epidemiology, Microbiome, Population Health, Clinical Trials, Cancer Prevention

    Pneumonia, Infectious Complications, Bronchiolitis Obliterans, Stem Cell Transplant Recipients, Microbiome, Risk assessment

    Population Science and Prevention Program 

    Research profile

  • Publications

      Journal Article

      Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T, Lai Z, Rourke E, Basler J, Ankerst D, Shah DP. Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer European Urology 2018 Aug;. Sheshadri A, Shah DP, Godoy M, Erasmus J, Song J, Li L, Evans SE, Chemaly R, Dickey B, Ost D. Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections Plos One 2018 May;5(13). Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients Journal of Infectious Diseases 2018 Mar;217(8):1247-1256. Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers Journal of Medical Virology 2018 Jan;90(1):50-60. El Chaer F, Shah DP, Kmeid J, Ariza-Heredia E, Hosing CM, Mulanovich V, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes Cancer 2017 Jun;123(12):2329-2337. Shah DP, Grimes C, Lai D, Hwang LY. Hepatitis C Incidence and Spontaneous Viral Clearance in a Cohort of Human Immunodeficiency Virus and Hepatitis B Virus Negative Drug Users Annals of Infectious Disease and Epidemiology 2017 Mar;2(2). El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients Blood 2016 Dec;128(23):2624-2636. El Chaer F, Mori N, Shah DP, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series Antiviral Research 2016 Nov;135:91-96. El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia E, Mulanovich V, Gulbis A, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience Antiviral Research 2016 Oct;134:58-62. Langman L, Nesher L, Shah DP, Azzi J, Shpall EJ, Rezvani K, Black JL, Chemaly RF. Challenges in determining genotypes for pharmacogenetics in allogeneic hematopoietic cell transplant recipients Journal of Molecular Diagnostics 2016 Sep;18(5):638-42. Frenzel E, Chemaly RF, Ariza EH, Jiang Y, Shah DP, Thomas E, Graviss L, Raad I. Association of increased influenza vaccination in healthcare workers with a reduction in nosocomial influenza infections in cancer patients American Journal of Infection Control 2016 Sep;44(9):1016-21. Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RFShah DP. Utility of the enzyme-linked immunospot interferon-y-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients Journal of Infectious Diseases 2016 Jun;213(11):1701-7. Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review Cancer Letters 2016 May;397(1):100-6. Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza Heredia E, Hosing C, Mulanovich V, Chemaly RF. Outcomes of influenza infections in hematopoietic cell transplant recipients: Application of an Immunodeficiency Scoring Index Biology of Blood and Marrow Transplantation 2016 Mar;22(3):542-8. Shah DP, Shah PK, Azzi JM, Chemaly RF. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review Cancer letters 2016 Jan;370(2):358-64. Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji S, Maichailidis L, Marsh L, Chemaly RF. Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members Infection Control & Hospital Epidemiology 2015 Oct;36(10):1239-41. Nesher L, Rolston K, Shah DP, Tarrand J, Mulanovich V, Ariza-Heredia E, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation Transplant Infectious Disease 2015 Feb;17(1):33-8. Avadhanula V, Chemaly RF, Shah DP, Ghantoji SS, Azzi JM, Aideyan L, Mei M, Piedra PA. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013 Journal of Infectious Diseases 2015 Feb;211(4):582-9. Ariza-Heredia EJ, Gulbis A, Kebriae P, Stolar K, Shah DP, McConn K, Mulanovich V, Viola G, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: Practitioners? knowledge, attitudes and gap between guidelines and clinical practice Transplant Infectious Disease 2014 Dec;16(6):878-86. Wu Q, Xue XF, Shah DP, Zhao J, Hwang LY, Zhuang G. Knowledge, attitude, and practices regarding occupational HIV exposure and protection among health care workers in China: census survey in a rural area J Int Assoc Providers of AIDS Care (JIAPAC) 2014 Nov;15(5):363-9. Chemaly RF, Shah DP, Boeckh M. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies Clinical Infectious Diseases Supplement 2014 Nov;59(5):S344-S351. Nesher L, Chemaly RF, Shah DP, Mulanovich V, Hosing C, Rolston K. The utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center American Journal of Infection Control 2014 Oct;42(10):1084-8. Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand J, LiPuma J, Guh A, MacCannell T, Raad I, Mulanovich V. Cluster and sporadic cases of Herbaspirillum spp. infections in patients with cancer Clinical Infectious Diseases 2014 Sep;60(1):48-54. Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E. Respiratory syncytial virus infections in children with cancer J Pediatric Hematology/Oncology 2014 Aug;36(6):e376-81. Shah DP, Grimes CZ, Nguyen AT, Hwang LY. Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users American Journal of Public Health 2014 Jun;105(6):e36-43. Shah DP, Ghantoji SS, Ariza E, Shah JN, El Taoum K, Shah PK, Nesher L, Hosing CM, Rondon GB, Champlin R, Chemaly RF. An Immunodeficiency Scoring Index to predict poor outcomes in hematopoietic cell transplant recipients with respiratory syncytial virus infections Blood 2014 May;123(21):3263-3268. Kamath GK, Shah DP, Hwang LY. Immune response to hepatitis B vaccination in drug using population: a systematic review and meta-regression analysis Vaccine 2014 Apr;32(20):2265-74. Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Impact of aerosolized ribavirin on mortality in 280 allogeneic hematopoietic stem cell transplant recipients with respiratory syncytial virus infections J Antimicrobial Chemotherapy 2013 Aug;68(8):1872-1880.